4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Uni-Bio Science Group Limited (0690) operates in the Biotechnology industry and is headquartered in Sha Tin, Hong Kong with about 568 employees. Its market capitalization is roughly HK$430 million. In the fiscal year ended 2025-12-31, 0690 reported HK$586M in revenue and HK$93M in net income.
Uni-Bio Science Group Limited, an investment holding company, researches and develops, manufactures, and sells biological and chemical pharmaceutical products to treat human diseases in Hong Kong, and People's Republic of China.
Interactive charts & full statements → Open the 0690 valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | HK$586M | HK$553M | HK$485M | HK$440M | — |
| Gross Profit | HK$488M | HK$461M | HK$393M | HK$335M | — |
| Operating Income (EBIT) | HK$100M | HK$90M | HK$68M | HK$42M | — |
| Net Income | HK$93M | HK$83M | HK$71M | HK$38M | — |
HKD; HK$M / HK$B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dividends Paid | (HK$16M) | — | — | — | — |
HKD; HK$M / HK$B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | HK$580M | HK$518M | HK$410M | HK$292M | — |
| Total Liabilities | HK$167M | HK$192M | HK$153M | HK$98M | — |
HKD; HK$M / HK$B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 0690 viewer.
About TickerBase · Data methodology & sources · Privacy · Terms